New Technologies for Target Discovery and Validation

DATE

February 16, 2022

TIME

8:00 a.m. PST, 11:00 a.m. EST, 16:00 GMT, 17:00 CET

Duration: 60 Minutes

Overview

Novel target discovery and validation are the most crucial steps and prerequisites for successful drug development. This webinar will review comprehensive target discovery and validation platforms propelled by various new technologies, and extension to the challenging field of immunology, as well as expansion and utilization in multiple new modalities.

• Comprehensive target discovery and validation platforms propelled by CRISPR and other new technologies

• Gene editing in various human and mouse primary immune cells, and established TCR-T and CAR-T cell therapy platforms provide all-around services including surface antigen validation, in vitro and in vivo efficacy and functional assessment

• Advanced developments in PROTAC/Target Protein Degradation (TPD), Antibody-oligo conjugate (AOC) and RNA editing (ASO) new modalities

Key Learning Objectives:

Provide comprehensive solutions to novel target discovery and validation in various disease areas
Advanced platforms supporting hot new modalities such as TCR-T/CAR-T, PROTAC and AOC/ASO, etc., leveraging our strong capabilities
Mitigate risks for drug research with rigorous scientific investigation

Who Should Attend:

Drug discovery scientists
CSOs
Oncology/Cancer researchers
Immunologists

Brought to you by:

Speakers

Shelley (Fang) Zhang, M.D., Ph.D.
Director II,
WuXi AppTec

Catherine Dold
Health & Environment Writer,
C&EN Media Group

Registration

Forwarded this event? Clear the form

Email Address*

Salutation

First Name*

Last Name*

Company*

Job Title*

Address 1*

City*

State*

Zip / Post Code*

Country*

Business Phone*

Yes we are currently investigating possible use of (or are using) modalities such as PROTAC, CRISPR,

Yes, our approach to drug discovery includes use of bifunctional molecules, CRISPR, antisense oligon

I would like to receive more information on products and services from the American Chemical Society

address2

*By submitting this form, you agree to receive more information on related products and services from the American Chemical Society (ACS Publications) and its sponsor via email. ACS takes your privacy seriously. For more information, please see the ACS Privacy Policy.

View On Demand Webinars